Harpoon Therapeutics, Inc.
NASDAQ:HARP
23.01 (USD) • At close March 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 31.915 | 23.654 | 17.444 | 5.777 | 4.75 | 0.708 | 0 |
| Cost of Revenue
| 3.097 | 2.646 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 28.818 | 21.008 | 17.444 | 5.777 | 4.75 | 0.708 | 0 |
| Gross Profit Ratio
| 0.903 | 0.888 | 1 | 1 | 1 | 1 | 0 |
| Reseach & Development Expenses
| 81.393 | 72.124 | 52.565 | 41.592 | 26.368 | 13.622 | 7.778 |
| General & Administrative Expenses
| 18.847 | 18.327 | 16.21 | 22.391 | 6.106 | 3.614 | 3.369 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 18.847 | 18.327 | 16.21 | 22.391 | 6.106 | 3.614 | 3.369 |
| Other Expenses
| -0.182 | -0.21 | -0.026 | -0.042 | -0.037 | -0.017 | -0.004 |
| Operating Expenses
| 100.24 | 90.451 | 68.775 | 63.983 | 32.474 | 17.236 | 11.147 |
| Operating Income
| -68.325 | -116.751 | -51.331 | -58.206 | -27.724 | -16.528 | -11.147 |
| Operating Income Ratio
| -2.141 | -4.936 | -2.943 | -10.075 | -5.837 | -23.345 | 0 |
| Total Other Income Expenses Net
| 0.594 | 0.03 | 1.423 | 2.634 | -0.037 | -0.017 | -0.004 |
| Income Before Tax
| -67.731 | -116.721 | -49.908 | -55.572 | -27.366 | -16.83 | -11.406 |
| Income Before Tax Ratio
| -2.122 | -4.935 | -2.861 | -9.62 | -5.761 | -23.771 | 0 |
| Income Tax Expense
| -0.594 | 49.714 | -3.531 | -3.576 | 0.358 | 0.268 | 0.257 |
| Net Income
| -67.137 | -166.435 | -46.377 | -51.996 | -27.366 | -16.83 | -11.406 |
| Net Income Ratio
| -2.104 | -7.036 | -2.659 | -9.001 | -5.761 | -23.771 | 0 |
| EPS
| -20.24 | -51.57 | -18.52 | -23.91 | -11.45 | -17.81 | -1.21 |
| EPS Diluted
| -20.24 | -51.57 | -18.52 | -23.91 | -11.45 | -17.81 | -1.21 |
| EBITDA
| -68.325 | -14.653 | -51.331 | -58.206 | -27.366 | -16.179 | -10.947 |
| EBITDA Ratio
| -2.141 | -0.619 | -2.943 | -10.075 | -5.761 | -22.852 | 0 |